Literature DB >> 17051365

[Cleidocranial dysplasia. Description and analysis of a patient cohort].

U Baumert1, I Golan, O Driemel, T E Reichert, C Reicheneder, D Muessig, E Rose.   

Abstract

BACKGROUND: Cleidocranial dysplasia (CCD) is a rare dysplasia of bony and dental tissue. Characteristic are typical craniofacial and dental findings including morphological anomalies. CCD is possibly the only general syndrome that can be diagnosed based on the dental findings alone. CCD correlates with mutations in the RUNX2 gene.
PURPOSE: The present interdisciplinary study correlates phenotypic findings with genetic variations in the corresponding gene. PATIENTS AND METHODS: The coding sequence of the RUNX2 gene from 31 CCD patients from 20 families was analyzed using molecular genetic methods including polymerase chain reaction and direct sequencing. The craniofacial and dental findings of each patient were evaluated according to a standardized scoring scheme and tested with homogeneity analysis for general phenotypic findings.
RESULTS: Several mutations of the RUNX2 gene were identified. Depending on the mutation type, they showed different distribution patterns within the gene coinciding with the functional domains of the gene product. With homogeneity analysis of the phenotype cardinal (especially dental findings) and minor findings (pneumatization disturbances, Wormian bones) were identified. In combination with the genetic data, the statistical analysis showed that loss-of-function mutations of the RUNX2 gene result in a milder markedness of the CCD phenotype than gain-of-function or decrease-of-function mutations.
CONCLUSIONS: We found that type and location of a specific mutation within the RUNX2 gene might have an impact on the expressivity of CCD. Due to the limited sampling size this hypothesis must be verified by investigations in larger patient groups.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17051365     DOI: 10.1007/s10006-006-0029-1

Source DB:  PubMed          Journal:  Mund Kiefer Gesichtschir        ISSN: 1432-9417


  27 in total

1.  The leukemia-associated AML1 (Runx1)--CBF beta complex functions as a DNA-induced molecular clamp.

Authors:  J Bravo; Z Li; N A Speck; A J Warren
Journal:  Nat Struct Biol       Date:  2001-04

Review 2.  Oncogenic potential of the RUNX gene family: 'overview'.

Authors:  Yoshiaki Ito
Journal:  Oncogene       Date:  2004-05-24       Impact factor: 9.867

3.  Atypical expression of cleidocranial dysplasia: clinical and molecular-genetic analysis.

Authors:  I Golan; U Baumert; H Wagener; J Dauwerse; M Preising; B Lorenz; H Niederdellmann; D Müssig
Journal:  Orthod Craniofac Res       Date:  2002-11       Impact factor: 1.826

4.  Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.

Authors:  T Komori; H Yagi; S Nomura; A Yamaguchi; K Sasaki; K Deguchi; Y Shimizu; R T Bronson; Y H Gao; M Inada; M Sato; R Okamoto; Y Kitamura; S Yoshiki; T Kishimoto
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

5.  Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development.

Authors:  F Otto; A P Thornell; T Crompton; A Denzel; K C Gilmour; I R Rosewell; G W Stamp; R S Beddington; S Mundlos; B R Olsen; P B Selby; M J Owen
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

6.  CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia.

Authors:  G Zhou; Y Chen; L Zhou; K Thirunavukkarasu; J Hecht; D Chitayat; B D Gelb; S Pirinen; S A Berry; C R Greenberg; G Karsenty; B Lee
Journal:  Hum Mol Genet       Date:  1999-11       Impact factor: 6.150

7.  The classic: Marie, P., and Sainton P.: Sur la dysostose cleido-cranienne herediataire, Rev. neurol. 6:835, 1898. On hereditary cleido-cranial dysostosis.

Authors: 
Journal:  Clin Orthop Relat Res       Date:  1968 May-Jun       Impact factor: 4.176

8.  Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia.

Authors:  I Quack; B Vonderstrass; M Stock; A S Aylsworth; A Becker; L Brueton; P J Lee; F Majewski; J B Mulliken; M Suri; M Zenker; S Mundlos; F Otto
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

9.  Identification of novel CBFA1/RUNX2 mutations causing cleidocranial dysplasia.

Authors:  C Bergwitz; A Prochnau; B Mayr; F J Kramer; M Rittierodt; H L Berten; J E Hausamen; G Brabant
Journal:  J Inherit Metab Dis       Date:  2001-11       Impact factor: 4.982

Review 10.  Dentomaxillofacial variability of cleidocranial dysplasia: clinicoradiological presentation and systematic review.

Authors:  I Golan; U Baumert; B P Hrala; D Müssig
Journal:  Dentomaxillofac Radiol       Date:  2003-11       Impact factor: 2.419

View more
  3 in total

1.  The significance of RUNX2 in postnatal development of the mandibular condyle.

Authors:  Birgit Rath-Deschner; Nikolaos Daratsianos; Sarah Dühr; Niklas Girmann; Jochen Winter; Franziska Kroll; Christoph Reichert; Andreas Jäger; Werner Götz
Journal:  J Orofac Orthop       Date:  2010-02-05       Impact factor: 1.938

2.  [Immunohistochemical study on collagen I content in the gingiva in cleidocranial dysplasia].

Authors:  Tobias Ach; Uwe Baumert; Christian Morsczeck; Regine Dahse; Torsten Eugen Reichert; Oliver Driemel
Journal:  Mund Kiefer Gesichtschir       Date:  2007-12

3.  The role of periodontal ligament cells in delayed tooth eruption in patients with cleidocranial dysostosis.

Authors:  Stefan Lossdörfer; Bassel Abou Jamra; Birgit Rath-Deschner; Werner Götz; Rami Abou Jamra; Bert Braumann; Andreas Jäger
Journal:  J Orofac Orthop       Date:  2009-12-04       Impact factor: 1.938

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.